Ausgabe 3/2023
Special Issue: Cancer and Bone: Friendly and hostile relationship
Inhalt (15 Artikel)
Metastasis prevention with bone-targeted agents: a complex interaction between the microenvironment and tumour biology
Robert Coleman
Differences between zoledronic acid and denosumab for breast cancer treatment
Takashi Ishikawa
Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancer
Shunji Takahashi
Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis
Min-Kyoung Song, Serk In Park, Sun Wook Cho
Extracellular vesicles in bone homeostasis: key roles of physiological and pathological conditions
Takaaki Tamura, Yusuke Yoshioka, Shinichi Sakamoto, Tomohiko Ichikawa, Takahiro Ochiya
Wnt signaling: a double-edged sword in protecting bone from cancer
Xun Sun, Kexin Li, Bai-Yan Li, Hiroki Yokota
Immunotherapy as a potential treatment approach for currently incurable bone metastasis
Yang Yu, Jenna Ollodart, Kelly F. Contino, Yusuke Shiozawa
Factors associated with clonal hematopoiesis and interaction with marrow environment
Yasuhito Nannya
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
Jumpei Teramachi, Hirokazu Miki, Shingen Nakamura, Masahiro Hiasa, Takeshi Harada, Masahiro Abe
Cancer–nerve interplay in cancer progression and cancer-induced bone pain
Toshiyuki Yoneda, Masahiro Hiasa, Tatsuo Okui, Kenji Hata